•
Jun 30, 2022

Soleno Therapeutics Q2 2022 Earnings Report

EPS
-$0.9
Previous year: -$2.1
-57.1%
Cash and Equivalents
$24.1M
Previous year: $33.6M
-28.4%
Free Cash Flow
-$4.63M
Previous year: -$8.01M
-42.3%
Total Assets
$36.9M
Previous year: $48.8M
-24.4%

Soleno Therapeutics

Soleno Therapeutics